Expression of bone morphogenetic protein 6 in non‑small cell lung cancer and its significance

  • Authors:
    • Wei Xiong
    • Li Wang
    • Fenglei Yu
  • View Affiliations

  • Published online on: November 30, 2018     https://doi.org/10.3892/ol.2018.9781
  • Pages: 1946-1952
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The present study investigated the expression and clinical significance of bone morphogenetic protein 6 (BMP‑6) in patients with non‑small cell lung cancer (NSCLC). The tumor and adjacent normal lung tissues were harvested from 65 patients with NSCLC. BMP‑6 mRNA expression was measured by reverse transcription‑quantitative polymerase chain reaction, while protein expression was measured using immunohistochemistry or an ELISA. Cell viability was determined using Cell Counting Kit‑8. The association of BMP‑6 mRNA expression with the prognosis of patients with NSCLC was analyzed using the Kaplan‑Meier plotter database. BMP‑6 mRNA expression in NSCLC tumor tissues was significantly reduced, compared with the adjacent normal lung tissues (P<0.001), yet no significant differences were observed between patients with different clinicopathological features (P>0.05). The expression level of BMP‑6 protein in NSCLC tumor tissues was significantly reduced, compared with the adjacent normal lung tissues (P<0.05). Analysis with the Kaplan‑Meier plotter database revealed that patients with NSCLC with low BMP‑6 mRNA expression had a reduced overall survival rate (P<0.01). The active BMP6 protein significantly inhibited cell proliferation in H460, H1299, A549 and H520 cells. In conclusion, BMP‑6 is a tumor suppressor in lung cancer and loss of BMP‑6 expression is significantly associated with a poor prognosis in patients with NSCLC.
View Figures
View References

Related Articles

Journal Cover

February-2019
Volume 17 Issue 2

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Xiong W, Wang L and Yu F: Expression of bone morphogenetic protein 6 in non‑small cell lung cancer and its significance. Oncol Lett 17: 1946-1952, 2019.
APA
Xiong, W., Wang, L., & Yu, F. (2019). Expression of bone morphogenetic protein 6 in non‑small cell lung cancer and its significance. Oncology Letters, 17, 1946-1952. https://doi.org/10.3892/ol.2018.9781
MLA
Xiong, W., Wang, L., Yu, F."Expression of bone morphogenetic protein 6 in non‑small cell lung cancer and its significance". Oncology Letters 17.2 (2019): 1946-1952.
Chicago
Xiong, W., Wang, L., Yu, F."Expression of bone morphogenetic protein 6 in non‑small cell lung cancer and its significance". Oncology Letters 17, no. 2 (2019): 1946-1952. https://doi.org/10.3892/ol.2018.9781